Corcept Therapeutics (CORT) Prepaid Assets (2010 - 2026)
Corcept Therapeutics' (CORT) quarterly Prepaid Assets came in at $6.4 million in Q1 2026, down 83.87% year-on-year from $39.6 million in Q1 2025, and down 84.31% quarter-over-quarter from $40.7 million in Q4 2025.
Corcept Therapeutics (CORT) Prepaid Assets (2010 - 2026) Analysis & Trends
Corcept Therapeutics has disclosed Prepaid Assets across 17 years of filings, most recently posting $6.4 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $6.4 million, down 83.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.4 million (down 83.87% YoY), and the FY2025 annual result was $40.7 million, up 568.94% from the prior year.
- Prepaid Assets came in at $6.4 million for Q1 2026 at Corcept Therapeutics, down from $40.7 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $40.7 million in Q4 2025 to a low of $4.6 million in Q3 2024.
- The 5-year median for Prepaid Assets is $15.9 million (2023), against an average of $18.4 million.
- Across the five-year window, Prepaid Assets surged 718.1% in 2025 and plunged 83.87% in 2026, its largest moves.
- Corcept Therapeutics' Prepaid Assets stood at $16.4 million in 2022, then jumped by 67.82% to $27.6 million in 2023, then plunged by 77.95% to $6.1 million in 2024, then surged by 568.94% to $40.7 million in 2025, then tumbled by 84.31% to $6.4 million in 2026.
- The last three Prepaid Assets figures came in at $6.4 million (Q1 2026), $40.7 million (Q4 2025), and $37.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Corcept Therapeutics | 8.35 Bn | 8.01 Bn | 162.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.38 Mn |
| Dec 31, 2025 | 40.66 Mn |
| Sep 30, 2025 | 37.47 Mn |
| Jun 30, 2025 | 7.47 Mn |
| Mar 31, 2025 | 39.55 Mn |
| Dec 31, 2024 | 6.08 Mn |
| Sep 30, 2024 | 4.58 Mn |
| Jun 30, 2024 | 9.13 Mn |
| Mar 31, 2024 | 18.36 Mn |
| Dec 31, 2023 | 27.56 Mn |
| Sep 30, 2023 | 20.16 Mn |
| Jun 30, 2023 | 15.86 Mn |
| Mar 31, 2023 | 15.87 Mn |
| Dec 31, 2022 | 16.42 Mn |
| Sep 30, 2022 | 20.68 Mn |
| Jun 30, 2022 | 15.36 Mn |
| Mar 31, 2022 | 10.44 Mn |
| Dec 31, 2021 | 10.32 Mn |
| Sep 30, 2021 | 9.07 Mn |
| Jun 30, 2021 | 9.00 Mn |